Rodent carcinogenicity profile of the antidiabetic dual PPAR alpha and gamma agonist muraglitazar - Tannehill-Gregg, S H; Sanderson, T P; Minnema, D; Voelker, R; Ulland, B; Cohen, S M; Arnold, L L; Schilling, B E; Waites, C R; Dominick, M A (Toxicol Sci, 2007)